Ginkgo and Improved Processing Speed

Doses used in studies

Time to effect

Median: 4.2 months · IQR 4.2 months–4.2 months · Range 4.2 months–4.2 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
This study confirmed the favorable safety profile
from: Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defi
diarrheaReportedmost frequent events
Headache and diarrhea of mild-to-moderate severity were the most frequent events.
from: Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defi
headacheReportedmost frequent events
Headache and diarrhea of mild-to-moderate severity were the most frequent events.
from: Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defi
serious adverse eventReportedSerious adverse event2 events in 2 (1.3%) patients
Two serious adverse events, both considered unrelated to the study drug, occurred in 2 (1.3%) patients.
from: Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defi

1 of 1 paper

Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defined Ginkgo Biloba Extract for Adults with Major Neurocognitive Disorder.